These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combined inhibin and CA125 assays in the detection of ovarian cancer. Robertson DM, Cahir N, Burger HG, Mamers P, McCloud PI, Pettersson K, McGuckin M. Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351 [Abstract] [Full Text] [Related]
3. Inhibin forms in serum from postmenopausal women with ovarian cancers. Robertson DM, Cahir N, Burger HG, Mamers P, Groome N. Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065 [Abstract] [Full Text] [Related]
5. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Burger HG, Robertson DM, Cahir N, Mamers P, Healy DL, Jobling T, Groome N. Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307 [Abstract] [Full Text] [Related]
6. Total inhibin is a potential serum marker for epithelial ovarian cancer. Tsigkou A, Marrelli D, Reis FM, Luisi S, Silva-Filho AL, Roviello F, Triginelli SA, Petraglia F. J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066 [Abstract] [Full Text] [Related]
7. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. Robertson DM, Cahir N, Findlay JK, Burger HG, Groome N. J Clin Endocrinol Metab; 1997 Mar; 82(3):889-96. PubMed ID: 9062502 [Abstract] [Full Text] [Related]
8. Biological and immunological characterization of inhibin forms in human plasma. Robertson D, Burger HG, Sullivan J, Cahir N, Groome N, Poncelet E, Franchimont P, Woodruff T, Mather JP. J Clin Endocrinol Metab; 1996 Feb; 81(2):669-76. PubMed ID: 8636287 [Abstract] [Full Text] [Related]
9. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer. Phocas I, Sarandakou A, Sikiotis K, Rizos D, Kalambokis D, Zourlas PA. Anticancer Res; 1996 Feb; 16(6B):3827-31. PubMed ID: 9042265 [Abstract] [Full Text] [Related]
15. Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors. Ala-Fossi SL, Mäenpää J, Bläuer M, Tuohimaa P, Punnonen R. Eur J Endocrinol; 2000 Apr; 142(4):334-9. PubMed ID: 10754473 [Abstract] [Full Text] [Related]
16. Inhibins/activins as diagnostic markers for ovarian cancer. Robertson DM, Stephenson T, Pruysers E, Burger HG, McCloud P, Tsigos A, Groome N, Mamers P, McNeilage J, Jobling T, Healy D. Mol Cell Endocrinol; 2002 May 31; 191(1):97-103. PubMed ID: 12044923 [Abstract] [Full Text] [Related]
18. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma. Menon U, Riley SC, Thomas J, Bose C, Dawnay A, Evans LW, Groome NP, Jacobs IJ. BJOG; 2000 Sep 31; 107(9):1069-74. PubMed ID: 11002947 [Abstract] [Full Text] [Related]
19. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women]. Markova D, Milchev N, Batashki I, Uchikov A. Akush Ginekol (Sofiia); 2008 Sep 31; 47(1):16-9. PubMed ID: 18642569 [Abstract] [Full Text] [Related]